3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2451 |
GlyH-101
GlyH 101 |
CFTR; Autophagy | Autophagy; Membrane transporter/Ion channel |
GlyH-101 是一种可渗透入细胞的 CFTR 阻断剂,Ki 为1.4 uM。 | |||
T81539 | PAT1inh-B01 | ||
PAT1inh-B01为选择性SLC26A6抑制剂,抑制PAT1(Cl-/HCO3-交换器)介导的阴离子交换(IC50: 350 nM),并阻断小肠液体吸收,适用于小肠分泌不足相关疾病研究。 | |||
T71303 |
Flufenamic Acid-d4
|
||
Flufenamic acid-d4 is intended for use as an internal standard for the quantification of flufenamic acid by GC- or LC-MS. Flufenamic acid is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 3 and 9.3 µM for human COX-1 and COX-2, respectively). Flufenamic acid inhibits TNF-α-induced increases in COX-2 levels and NF-κB activation in HT-29 colon cancer cells in a concentration-dependent manner. It inhibits calcium influx induced by fMLP or A23187 in human polymorphonuclear... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5147 |
Tilifodiolide
|
IL Receptor; TNF; GABA Receptor | Apoptosis; Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience |
Tilifodiolide exerts in vitro and in vivo anti-inflammatory activity and in vivo antinociceptive effects. Tilifodiolide exerted antidiarrheal activity by decreasing the intestinal fluid accumulation and vasorelaxant effects mediated by nitric oxide and cyclic guanosine monophosphate, it also showed anxiolytic and antidepressant effects by the partial involvement of gamma-Aminobutyric acid (GABA) receptors and the possible participation of α2-adrenoreceptors, respectively. |